KwaZulu-Natal Health Department reports significant stabilisation in medicine availability, while grappling with critical ...

A study published March 17 in JAMA Network Open found that transgender, nonbinary and gender-diverse people who were ...

The Department of Health in KwaZulu-Natal has blamed a shortage of insulin on the global Ozempic frenzy. The medication, ...

The plant will make three types of insulin, which Civica has pledged to sell for $30 a vial and $55 for a box of five pens.

Xeris Biopharma Holdings, Inc. (Nasdaq: XERS), a growth-oriented biopharmaceutical company committed to improving patient ...

Civica Rx, a nonprofit pharmaceutical company founded in 2018 to combat drug shortages and high medication costs, is preparing for a transformative 2025. President and CEO Ned McCoy shared with Becker ...

A Newsom 2028 presidential run may be in the works based on the California governor's recent moves, but his failures could haunt a future White House bid.

With thousands of press releases published each month, it can be difficult to keep up with everything on PR Newswire. To help ...

Biocon said that its wholly owned subsidiary, Biocon Biologics announced strategic collaboration agreement with Civica, Inc. to expand access, affordability of Insulin Aspart in the United States.

Biocon Biologics and Civica Inc. not-for-profit generic drug and pharmaceutical company founded in 2018 to address and resolve life-saving drug shortages and affordability, has inked a strategic ...

Civica will commercialize the medicine for patients in the United States, after completion of development work and clinical ...

Biocon Biologics Ltd and Civica, Inc. today announced a strategic collaboration agreement to expand access and affordability of Insulin Aspart in the United States.